Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mohammed-Jaouad Belahcen"'
Autor:
Soumaya El Baraka, Jean-Marie Ouedraogo, Soumaya Arbai, Mohammed-Jaouad Belahcen, Younes Rahali
Publikováno v:
Le Pharmacien Clinicien. 57:243-253
Autor:
Yasmine Bendarkawi, Ali Cherif Chefchaouni, Sihame Lkhoyaali, Hafsa Bechar, Yassine Boudina, Youssef Abercha, Mohammed Jaouad Belahcen, Younes Rahali
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction Tamoxifen is widely used for the treatment of hormone-responsive breast cancer. In this article, we report a case of a patient who developed hand deformities following long-term administration of tamoxifen. Case report A 57-year-old woma
Autor:
Soumaya El Baraka, Younes Rahali, Joseph Sitsopeh, Mohammed Jaouad Belahcen, M Benabbes, Soumaya Arbai, Jean-Marie Ouedraogo
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 56:282-290
Summary Objective To show the place and the interest of dose readjustment in the non-administered chemotherapy preparations reallocation process. Materials and method This study is a retrospective study over a 6-month period. The reallocation process
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 56:185-192
Resume Contexte Notre etude porte sur un cas d’utilisation concomitante de tamoxifene et de boutons floraux du Syzygium aromaticum (girofle) par une patiente qui a developpe des effets indesirables : elevation des transaminases, de la bilirubine, i
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1630-1636
Purpose The purpose of this study was to assess the cost saved and the amount of drug wasted when compounding anticancer drugs in the centralized unit for chemotherapy preparation. A secondary objective was to estimate the centralization impact of ac
Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method
Autor:
Nihal Bhirich, Ali Cherif Chefchaouni, Safaa El Medkouri, Oumaima Shytry, Mohammed Jaouad Belahcen, Younes Rahali
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311536
Introduction Personnel involved in the preparation of cytotoxics are exposed to them and the resulting risks. To protect themselves, many means of protection are currently implemented. Nevertheless, the exposure of these manipulators remains a possib
Autor:
Chaimaa Nouibi, Ali Cherif Chefchaouni, Hafsa Bechar, Mohammed Jaouad Belahcen, Younes Rahali
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522211508
Introduction Capecitabine is a molecule of choice in the therapeutic arsenal of anticancer drugs used in Morocco for the treatment of breast cancer and colorectal cancer. Its frequent use imposes a follow-up and a post-prescription monitoring of the
Autor:
Ali Cherif Chefchaouni, Yassine Boudina, Meryem Chennaq, Mohammed Jaouad Belahcen, Younes Rahali
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522211188
Introduction In the last few years, pharmaceutical technology has evolved. In the field of oncology pharmacy, robots for the preparation of anti-cancer drugs have appeared to progressively replace manual preparation. The objective of this study is to
Autor:
Abou Sessouma, Younes Rahali, Soumaya El Baraka, Mohammed Jaouad Belahcen, Casimir Adade Adade, Joseph Sitsopeh, Jean-Marie Ouedraogo
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(4)
Objective The purpose of our study was to evaluate the contribution of an automated drug dispensing system in securing cancer chemotherapy production process at the pharmacy of the National Institute of Oncology in Rabat. Methods The failure modes an
Autor:
Soumaya Arbai, Abou Sessouma, Soumaya El Baraka, Mohammed-Jaouad Belahcen, Jean-Marie Ouedraogo, Younes Rahali
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522110133
Objective Automated Drug Supplying and management System (ADS) are effective devices that secure drug’s circuit and reduce hospital’s expenses. The purposes of this study are to estimate the earnings made from ADS through a cost-benefit medical e